Alturfan, Ahmet AtaBaşar, IşıkEmekli-Alturfan, EbruAyan, FarukKoldaş, LaleEmekli, Nesrin10.07.20192019-07-1010.07.20192019-07-102014Alturfan, A. A., Başar, I., Emekli-Alturfan, E., Ayan, F., Koldaş, L. ve Emekli, N. (2014). Galectin-3 and plasma cytokines in patients with acute myocardial infarction. Labmedicine, 45(4), 332-337. https://dx.doi.org/10.1309/LM3JZKBDA7D4QFOC0007-50271943-7730https://dx.doi.org/10.1309/LM3JZKBDA7D4QFOChttps://hdl.handle.net/20.500.12511/3370WOS: 000343954700009PubMed ID: 25316666Objective: To investigate the concentrations of plasma cytokines and Galectin-3 (Gal-3) as inflammatory markers in patients with acute myocardial infarction (AMI). Methods: The study population consisted of 29 patients with AMI and 29 healthy control subjects. We measured Gal-3, tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6) levels in plasma using enzyme-linked immunosorbent assays (ELISAs). We measured levels of C-reactive protein (CRP) via the nephelometric method. Results: Patients with AMI showed significantly higher plasma Gal-3, TNF-alpha, and IL-6 levels compared with controls. Gal-3 levels were positively and significantly correlated with plasma IL-6, TNF-alpha, and CRP levels in the control and patient groups. Conclusion: Our findings suggest that Gal-3 can be a new circulating biomarker of inflammation associated with AMI.eninfo:eu-repo/semantics/openAccessGalectin-3AMIInflammationCytokinesCRPTNF-AlphaArticle45433233710.1309/LM3JZKBDA7D4QFOCQ4N/A